Blood Res.  2017 Dec;52(4):332-334. 10.5045/br.2017.52.4.332.

Does the c.-273T>C variant in the upstream region of the HBB gene cause a thalassemia phenotype?

• Dastsooz H
• Alipour M
• Mohammadi
• Dehghanian F
• Kamgarpour F
• Fardaei M

• KMID: 2405076
• DOI: http://doi.org/10.5045/br.2017.52.4.332

Abstract

No abstract available.

MeSH Terms

Phenotype*
Thalassemia*

Reference

1. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011; 118:3479–3488.

2. Galanello R, Sanna S, Perseu L, et al. Amelioration of Sardinian beta0 thalassemia by genetic modifiers. Blood. 2009; 114:3935–3937.

3. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006; 37:12–20.

4. Huehns ER, Dance N, Beaven GH, Heclht F, Motulsky AG. Human embryonic hemoglobins. Cold Spring Harb Symp Quant Biol. 1964; 29:327–331.

5. Villegas A, Ropero P, González FA, Anguita E, Espinós D. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin. 2001; 25:273–283.

6. Nadkarni A, Gorakshakar AC, Lu CY, et al. Molecular pathogenesis and clinical variability of beta-thalassemia syndromes among Indians. Am J Hematol. 2001; 68:75–80.

7. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005; 353:1135–1146.

8. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008; 112:3927–3938.

9. Nagar R, Sinha S, Raman R. Genotype-phenotype correlation and report of novel mutations in β-globin gene in thalassemia patients. Blood Cells Mol Dis. 2015; 55:10–14.